Literature DB >> 10192518

The prevalence of age-related maculopathy by geographic region and ethnicity.

R Klein1, B E Klein, K J Cruickshanks.   

Abstract

The prevalence of age-related maculopathy (ARM) varies considerably in different locations and racial/ethnic groups around the world. At present there are insufficient data to determine whether it is likely that these differences in prevalence, especially for the early forms of ARM are due to variations in genetic and environmental factors or due to variations in age of the cohorts and methods used to ascertain and define ARM. In three population-based studies of whites living in Beaver Dam, Wisconsin, Blue Mountains, Australia, and Rotterdam, The Netherlands, in which similar methods of ascertainment and classification were used to detect and define ARM, late ARM was present in 1.2%, 1.4%, and 1.2% of the population less than 86 years of age, respectively. While data from clinical studies suggest that late ARM associated with choroidal neovascularization is rare in blacks compared with whites, some epidemiological studies suggest that late ARM may be similar in blacks and whites. There are still too few data from various ethnic/racial groups around the world and too few population-based data in older Hispanic and Asian populations to make meaningful comparisons. There is a need for further research into the distribution of ARM and its possible causes using similar methodologies to ascertain and define the disease. Further insights will be gained when genotypes associated with ARM are discovered.

Entities:  

Mesh:

Year:  1999        PMID: 10192518     DOI: 10.1016/s1350-9462(98)00025-1

Source DB:  PubMed          Journal:  Prog Retin Eye Res        ISSN: 1350-9462            Impact factor:   21.198


  38 in total

Review 1.  Epidemiology of age-related maculopathy: a review.

Authors:  Redmer van Leeuwen; Caroline C W Klaver; Johannes R Vingerling; Albert Hofman; Paulus T V M de Jong
Journal:  Eur J Epidemiol       Date:  2003       Impact factor: 8.082

2.  Is our current clinical classification of AMD up to the job?

Authors:  G Malek; S W Cousins
Journal:  Br J Ophthalmol       Date:  2006-09       Impact factor: 4.638

3.  Morphologic and histopathologic change of sodium iodate-induced retinal degeneration in adult rats.

Authors:  Yang Liu; Ying Li; Chenguang Wang; Yinan Zhang; Guanfang Su
Journal:  Int J Clin Exp Pathol       Date:  2019-02-01

4.  Risk factors for the incidence of Advanced Age-Related Macular Degeneration in the Age-Related Eye Disease Study (AREDS) AREDS report no. 19.

Authors:  Traci E Clemons; Roy C Milton; Ronald Klein; Johanna M Seddon; Frederick L Ferris
Journal:  Ophthalmology       Date:  2005-04       Impact factor: 12.079

5.  [Photodynamic therapy of AMD for the first (better sight) and the second (worse sight) eyes].

Authors:  A C Marti; F K P Sutter; D Barthelmes; J C Fleischhauer; M M Kurz-Levin; M M Bosch; H Helbig
Journal:  Ophthalmologe       Date:  2007-02       Impact factor: 1.059

6.  Prevalence and risks factors of age-related macular degeneration in Oklahoma Indians: the Vision Keepers Study.

Authors:  Amir L Butt; Elisa T Lee; Ronald Klein; Dana Russell; Gerald Ogola; Ann Warn; Ronald M Kingsley; Jeunliang Yeh
Journal:  Ophthalmology       Date:  2011-02-18       Impact factor: 12.079

7.  A hapten generated from an oxidation fragment of docosahexaenoic acid is sufficient to initiate age-related macular degeneration.

Authors:  Joe G Hollyfield; Victor L Perez; Robert G Salomon
Journal:  Mol Neurobiol       Date:  2010-03-12       Impact factor: 5.590

8.  Age-Related Macular Degeneration: Epidemiology and Clinical Aspects.

Authors:  Tiarnán D L Keenan; Catherine A Cukras; Emily Y Chew
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

9.  Visual outcome of ranibizumab therapy for neovascular age related macular degeneration in the black population: a report of five cases.

Authors:  Roopa Vemala; Bhaskar Gupta; Sobha Sivaprasad
Journal:  Clin Ophthalmol       Date:  2010-08-19

10.  Oxidative damage-induced inflammation initiates age-related macular degeneration.

Authors:  Joe G Hollyfield; Vera L Bonilha; Mary E Rayborn; Xiaoping Yang; Karen G Shadrach; Liang Lu; Rafael L Ufret; Robert G Salomon; Victor L Perez
Journal:  Nat Med       Date:  2008-01-27       Impact factor: 53.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.